We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Verrica Pharmaceuticals Inc
6 own
10 watching
Current Price
$0.72
$-0.01
(-0.96%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
337.26M
52-Week High
11.41000
52-Week Low
0.61100000
Average Volume
0.23M
Dividend Yield
--
P/E Ratio
--
Market Capitalization337.26M52-Week High11.4100052-Week Low0.61100000Average Volume0.23MDividend Yield--P/E Ratio--What does the Verrica Pharmaceuticals Inc do?
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company s lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Read More
How much money does Verrica Pharmaceuticals Inc make?
News & Events about Verrica Pharmaceuticals Inc.
Globe Newswire
1 year ago
WEST CHESTER, Pa., April 12, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica or, the Company) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the first patient has been dosed in Part 2 of...
Zolmax
1 year ago
Entrada Therapeutics (NASDAQ:TRDA Get Rating) and Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, ...
Ticker Report
1 year ago
Royal Bank of Canada upgraded shares of Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) from a sector perform rating to an outperform rating in a report released on Monday, Marketbeat reports. The brokerage currently has $11.00 price objective on the stock. Verrica Pharmaceuticals Price ...
Globe Newswire
2years ago
Registration Stability Batch for VP-102 Completed and Placed on Stability Process Validation Batches Successfully Manufactured Verrica Reaffirms its Expected Q1 2023 NDA Resubmission for VP-102 WEST CHESTER, Pa., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA...
Ticker Report
2years ago
Verrica Pharmaceuticals (NASDAQ:VRCA Get Rating) and Lexicon Pharmaceuticals (NASDAQ:LXRX Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, ...
Frequently Asked Questions
Frequently Asked Questions
What is Verrica Pharmaceuticals Inc share price today?
Can Indians buy Verrica Pharmaceuticals Inc shares?
How can I buy Verrica Pharmaceuticals Inc shares from India?
Can Fractional shares of Verrica Pharmaceuticals Inc be purchased?
What are the documents required to start investing in Verrica Pharmaceuticals Inc stocks?
What is today’s traded volume of Verrica Pharmaceuticals Inc?
What is today’s market capitalisation of Verrica Pharmaceuticals Inc?
What is the 52-Week High and Low Range of Verrica Pharmaceuticals Inc?
What percentage is Verrica Pharmaceuticals Inc down from its 52-Week High?
What percentage is Verrica Pharmaceuticals Inc up from its 52-Week Low?
Current Price
$0.72
$-0.01
(-0.96%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.